MedTrace Logo

Cataract Surgery in Patients With Pseudoexfoliation and Pseudoexfoliation Glaucoma

NCT04590651 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2022-03-23

No results posted yet for this study

Summary

The study aims to document the effect cataract surgery has on the pseudoexfoliation and pseudoexfoliation glaucoma eye. Details such has patient history, history of possible glaucoma, intraocular pressure, status of the eye, operation parameters and postoperative effect will be documented. The study is prospective and randomised . Patients will be divided in to two groups: in one standard phacoemulsification cataract surgery will be preformed. In the second group the anterior chamber angel will be aspirated an extra minute at the end of the case with the IA probe. The aim is to determine weather this extra aspiration will have an effect on postoperative intraocular pressure and other parameters.

Conditions

  • Pseudoexfoliation
  • Pseudoexfoliation Syndrome
  • Pseudoexfoliation Glaucoma
  • Cataract

Interventions

PROCEDURE

Cataract surgery

Routine phacoemulsification cataract surgery using the Alcon Centurion® device.

PROCEDURE

Cataract surgery with extra anterior chamber angle aspiration

Routine phacoemulsification cataract surgery using the Alcon Centurion® device. At the end of the case a one minute extra anterior chamber angle aspiration will be preformed after the removal of the viscoelastic agent.

Sponsors & Collaborators

  • Peeter Kuddu

    lead OTHER

Principal Investigators

  • Kari Krootila, AP · Helsinki University Central Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-11
Primary Completion
2023-06-11
Completion
2023-12-11

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04590651 on ClinicalTrials.gov